Pathogenesis of ganglion "cell death" in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria

Progress in Brain Research

Volumn 173, Issue , 2008, Pages 339-352

  Osborne, Neville N ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

lipoic acid; apoptosis; creatine; epigallocatechin gallate; ganglion cells; light injury to mitochondria; mitochondria; neuroprotection; nicotinamide; pathogenesis of glaucoma

Indexed keywords

CREATININE; EPIGALLOCATECHIN GALLATE; GLUTAMIC ACID; NICOTINAMIDE; NITRIC OXIDE; THIOCTIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ASTROCYTE; CELL FUNCTION; DRUG MEGADOSE; ENERGY YIELD; EYE BLOOD FLOW; GLAUCOMA; MITOCHONDRION; NERVE CELL NECROSIS; NERVE CONDUCTION; NEUROPROTECTION; NONHUMAN; NONMYELINATED NERVE; OPTIC NERVE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RETINA GANGLION CELL; REVIEW;

ANTIOXIDANTS; AXONS; CATECHIN; CELL DEATH; CREATINE; GLAUCOMA; HUMANS; MITOCHONDRIA; NEUROPROTECTIVE AGENTS; NIACINAMIDE; OPTIC DISK; RETINAL GANGLION CELLS; THIOCTIC ACID; VITAMIN B COMPLEX;

EID: 53049110307     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(08)01124-2     Document Type: Review

References (59)

1. Abu-Amero K.K., Morales J., and Bosley T.M. Mitochondrial abnormalities in patients with primary open-angle glaucoma. Invest. Ophthalmol. Vis. Sci. 47 (2006) 2533-2541
2. Biewenga G.P., Haenen G.R., and Bast A. The pharmacology of the antioxidant lipoic acid. Gen. Pharmacol. 29 (1997) 315-331
3. Brewer G.J., and Wallimann T.W. Protective effect of the energy precursor creatine against toxicity of glutamate and β-amyloid in rat hippocampal neurons. J. Neurochem. 74 (2000) 1968-1979
4. Bristow E.A., Griffiths P.G., Andrews R.M., Johnson M.A., and Turnbull D.M. The distribution of mitochondrial activity in relation to optic nerve structure. Arch. Ophthalmol. 120 (2002) 791-796
5. Carelli V., Ross-Cisneros F.N., and Sadun A.A. Mitochondrial dysfunction as a cause of optic neuropathies. Prog. Retin. Eye Res. 24 (2004) 53-90
6. Chan D.C. Mitochondria: dynamic organelles in disease, ageing, and development. Cell 125 (2006) 1241-1252
7. Chen E., Soderberg P.G., and Lindstrom B. Cytochrome oxidase activity in rat retina after exposure to 404 nm blue light. Curr. Eye Res. 11 (1992) 825-831
8. Chen Q., Vazquez E.J., Moghaddas S., Hoppel C.L., and Lesnefsky E.J. Production of reactive oxygen species by mitochondria: central role of complex III. J. Biol. Chem. 278 38 (1992) 36027-36031
9. Chidlow G., Schmidt K.-G., Wood J.P.M., Melena J., and Osborne N.N. α-Lipoic acid protects the retina against ischemia-reperfusion. Neuropharmacology 43 (2002) 1015-1025
10. Cosi C., and Marien M. Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): prevention by the poly (ADP-ribose) polymerase inhibitor, benzamide. Brain Res. 809 (1998) 58-67
11. Dryer E.B., Zurakowski D., Schumer R.A., Podos S.M., and Lipton S.A. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch. Ophthalmol. 114 (1996) 299-305
12. Eliasson M.J.L., Sampei K., Madir A.S., Hurn P.D., Traystman R.J., Bao J., Pieper A., Wang Z.Q., Dawson T.M., Snyder S.H., and Dawson V.L. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat. Med. 3 (1997) 1089-1095
13. Flammer J., and Orgül S. Optic nerve blood-flow abnormalities in glaucoma. Prog. Retin. Eye Res. 17 (1998) 267-289
14. Flammer J., Orgül S., Costa V.P., Orzalesi N., Krieglstein G.K., Serra L.M., Renard J.-P., and Stefansson E. The impact of ocular blood flow in glaucoma. Prog. Retin. Eye Res. 21 (2002) 359-393
15. Freisleben H.J. Lipoic acid reduces ischemia-reperfusion injury in animal models. Toxicology 148 (2000) 159-171
16. Godley B.F., Shamsi F.A., Liang F.Q., Jarrett S.G., Davies S., and Boulton M. Blue light induces mitochondrial DNA damage and free radical production in epithelial cells. J. Biol. Chem. 280 (2005) 21061-21066
17. Green D.R., and Reed J.C. Mitochondria and apoptosis. Science 281 (1998) 1309-1312
18. Isbrucker R.A., Bausch J., Edwards J.A., and Wolz E. Safety studies on epigallocatechin gallate (EGCG) preparations. Part 1: genotoxicity. Food Chem. Toxicol. 44 (2006) 626-635
19. Ji D., Li G.-U., and Osborne N.N. Nicotinamide attenuates retinal ischemia and light insults to neurones. Neurochem. Int. 52 (2008) 786-798
20. King A., Gottlieb E., Brooks D.G., Murphy M.P., and Dunaief J.L. Mitochondria-derived reactive oxygen species mediate blue light-induced death of retinal pigment epithelial cells. Photochem. Photobiol. 79 (2004) 470-475
21. Klivenyi P., Ferrante R.J., and Matthews R.T. Neuroprotective effects of creatine in a transgenic animal model of ALS. Nat. Med. 5 (1998) 347-350
22. Kroemer G., and Reed J.C. Mitochondrial control of cell death. Nat. Med. 6 (2000) 513-519
23. Lascaratos G., Ji D., Wood J.P.M., and Osborne N.N. Visible light affects mitochondrial function and induces neuronal death in retinal cell cultures. Vision Res. 47 (2007) 1191-1201
24. Lawler J.M., Barnes W.S., Wu G., Song W., and Demaree S. Direct antioxidant properties of creatine. Biochem. Biophys. Res. Commun. 290 (2002) 47-52
25. Levy N.S. The effect of interruption of the short ciliary arteries on slow axoplasmic transport and histology within the optic nerve of the rhesus monkey. Invest. Ophthalmol. 15 (1976) 405-410
26. Mandel S.A., Avramovich-Tirosh Y., Reznichenko L., Zheng H., Weinreb O., Amit T., and Youndim M.B.H. Multifunctional activities of green tea catechins in neuroprotection. Neurosignals 14 (2005) 46-60
27. Mandir A.S., Przedborski S., Jackson-Lewis V., Wang Z.Q., Simbulan-Rosenthal C.M., Smulson M.E., Hoffman B.E., Guastella D.B., Dawson V.L., and Dawson T.M. Poly (ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 5774-5779
28. McLennan H.R., and Degli Esposti M. The contribution of mitochondrial respiratory complexes to the production of reactive oxygen species. J. Bioenerg. Biomembr. 32 (2000) 153-162
29. Mitscher L.A., Jung M., Shankel D., Dou J.-H., Steele L., and Pillai S.P. Chemoprotection: a review of the potential therapeutic antioxidant properties of green tea (Camellia sinensis) and certain of its constituents. Med. Res. Rev. 17 (1997) 327-365
30. Mitsui Y., Schmelzer J.D., Zollman P.J., Mitsui M., Tritschler H.J., and Low P.A. Alpha-lipoic acid provides neuroprotection from ischemia-reperfusion injury of peripheral nerve. J. Neurol. Sci. 163 (1999) 11-16
31. Morin C., and Simon N. Mitochondria: a target for neuroprotective intervention in cerebral ischemia-reperfusion. Curr. Pharm. Des. 12 (2006) 739-757
32. Neufeld A.H., Sawada A., and Becker B. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc. Nat. Acad. Sci. U.S.A. 96 (1999) 9944-9948
33. Obrosova I.G., Stevens M.J., and Lang H.J. Diabetes-induced changes in retinal NAD-redox status: pharmacological modulation and implications for pathogenesis of diabetic retinopathy. Pharmacology 62 (2001) 172-180
34. Osborne N.N., Lascaratos G., Bron A.J., Chidlow G., and Wood J.P.M. A hypothesis to suggest that light is a risk factor in glaucoma and the mitochondrial optic neuropathies. Br. J. Ophthalmol. 90 (2006) 237-241
35. Osborne N.N., Li G.-Y., Ji D., Mortiboys H.J., and Jackson S. Light affects mitochondria to cause apoptosis to cultured cells: possible relevance to ganglion cell death in certain optic neuropathies. J. Neurochem. 105 (2008) 2013-2028
36. Osborne N.N., Melena J., Chidlow G., and Wood J.P.M. A hypothesis to explain cell death caused by vascular insults to the optic nerve head: possible implication for the treatment of glaucoma. Br. J. Ophthalmol. 85 (2001) 1252-1259
37. Osborne N.N., Ugarte M., Chao M., Chidlow G., Bae J.H., Wood J.P.M., and Nash M.S. Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv. Ophthalmol. 43 Suppl 1 (1999) S102-S128
38. Pache M., and Flammer J. A sick eye in a sick body? Systemic findings in patients with primary open-angle glaucoma. Surv. Ophthalmol. 51 (2006) 179-212
39. Packer L., Tritschler H.J., and Wessel K. Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radic. Biol. Med. 22 (1997) 359-378
40. Peng T.I., Jou M.G., Sheu S.S., and Greenamyre J.T. Visualization of NMDA receptor-induced mitochondrial calcium accumulation in striatal neurons. Exp. Neurol. 149 (1998) 1-12
41. Quigley H.A. Neuronal death in glaucoma. Prog. Retin. Eye Res. 18 (1999) 39-57
42. Sadanaga-Akiyoshi F., Yao H., Tanuma S., Nakahara T., Hong J.S., Ibayashi S., Uchimura H., and Fujishima M. Nicotinamide attenuates focal ischemic brain injury in rats: with special reference to changes in nicotinamide and NAD+ levels in ischemic core and penumbra. Neurochem. Res. 28 (2003) 1227-1234
43. Schon E.A., and Manfredi G. Neuronal degeneration and mitochondrial function. J. Clin. Invest. 111 (2003) 303-312
44. 2+ responses in muscles with combined mitochondrial and cystolic creatine kinase deficiencies. Cell 89 (1997) 93-103
45. 3H](-)- epigallocatechin gallate, a cancer preventive tea polyphend, in mouse tissue. Carcinogenesis 10 (1998) 1771-1776
46. Tezel G. Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog. Retin. Eye Res. 25 (2006) 490-513
47. Tezel G., and Wax M.B. Hypoxia-inducible factor 1-alpha in the glaucomatous retina and optic nerve head. Arch. Ophthalmol. 122 (2004) 1348-1356
48. Thiagarajan G., Chandani S., Sundari C.S., Rao S.H., Kulkarni A.V., and Balasubramanian D. Antioxidant properties of green and black tea, and their potential ability to retard the progression of eye lens cataract. Exp. Eye Res. 73 (2001) 393-401
49. Tirosh O., Sen C.K., Roy S., Kobayashi M.S., and Packer L. Neuroprotective effects of alpha-lipoic acid and its positively charged amide analogue. Free Radic. Biol. Med. 26 (1999) 1418-1426
50. Vinson J.A., and Zhang J. Black and green teas equally inhibit diabetic cataracts in a streptozotocin-induced rat model of diabetes. J. Agric. Food Chem. 53 (2005) 3710-3713
51. Wang L., Dong J., Cull G., Fortune B., and Cioffi G.A. Varicosities of intraretinal ganglion cell axons in human and nonhuman primates. Invest. Ophthalmol. Vis. Sci. 44 (2003) 2-9
52. Weinreb R.N., and Khaw P.T. Primary open-angle glaucoma. Lancet 363 (2004) 1711-1720
53. Whitmore A.V., Libby R.T., and John S.W.M. Glaucoma: thinking in new ways - a role for autonomous axonal self-destruction and other compartmentalised processes?. Prog. Retin. Eye Res. 24 (2005) 639-662
54. Wyss M., and Kaddurah-Daouk R. Creatine and creatine metabolism. Physiol. Rev. 80 (2000) 1107-1213
55. Zhang B., and Osborne N.N. Oxidative-induced retinal degeneration is attenuated by epigallocatechin gallate. Brain Res. 1124 (2006) 176-187
56. Zhang B., Rusciano D., and Osborne N.N. Orally administered epigallocatechin gallate attenuates retinal neuronal death in vivo and light-induced apoptosis in vitro. Brain Res. 1198 (2008) 141-152
57. Zhang B., Safa R., Rusciano D., and Osborne N.N. Epigallocatechin gallate, an active ingredient from green tea, attenuates damaging influences to the retina caused by ischemia/reperfusion. Brain Res. 1159 (2007) 40-53
58. Zhu M., Chen Y., and Li R.C. Oral absorption and bioavailability of tea catechins. Planta Med. 66 (2000) 444-447
59. Zhu S., Mingwei Li., Figueroa B.E., Liu A., Stavrovskaya I.G., Pasinelli P., Beal M.F., Brown R.H., Kristal B.S., Ferrante R.J., and Friedlander R.M. Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice. J. Neurosci. 24 (2004) 5909-5912